JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morishima, C.
Right arrow Articles by Gretch, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morishima, C.
Right arrow Articles by Gretch, D. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2004, p. 421-425, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.421-425.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Strengths and Limitations of Commercial Tests for Hepatitis C Virus RNA Quantification

Chihiro Morishima,1,2 Minjun Chung,2 Ka Wing Ng,2 Donald J. Brambilla,4 and David R. Gretch2,3*

Departments of Pediatrics,1 Laboratory Medicine,2 Medicine, University of Washington School of Medicine, Seattle, Washington,3 New England Research Institutes, Watertown, Massachusetts4

Received 20 February 2003/ Returned for modification 17 April 2003/ Accepted 24 September 2003

The sensitivity of the Roche COBAS Monitor v.2.0 test was slightly better than that of the Bayer bDNA 3.0 test, but the Monitor test underquantified specimens by 2.5- to 10.6-fold even at relatively low hepatitis C virus RNA concentrations. Dilution prior to assay minimally decreased the reproducibility of the Monitor assay, leading to the recommendation for all specimens to be diluted 1:100 prior to testing by this assay.

* Corresponding author. Mailing address: 325 9th Ave., Box 359690, Harborview Medical Center, Seattle, WA 98104-2499. Phone: (206) 341-5216. Fax: (206) 341-5203. E-mail: gretch{at}u.washington.edu.

Journal of Clinical Microbiology, January 2004, p. 421-425, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.421-425.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.